Assessment of a new cardioplegic solution for long-term heart preservation: experimental study using 31P magnetic resonance spectroscopy and biochemical analyses.
Bernard
M
M
Centre de Résonance Magnétique Biologique et Médicale (CRMBM), URA CNRS 1186, Faculté de Médecine de Marseille, France.
Caus
T
T
Sciaky
M
M
Monties
J R
JR
Cozzone
P J
PJ
D000255:Adenosine Triphosphate / Q000378:metabolism; D000493:Allopurinol; D000818:Animals; D002314:Cardioplegic Solutions; D003402:Creatine Kinase / Q000378:metabolism; D005978:Glutathione; D006321:Heart; D006323:Heart Arrest; D006863:Hydrogen-Ion Concentration; D009682:Magnetic Resonance Spectroscopy; D017202:Myocardial Ischemia; D009206:Myocardium / Q000378:metabolism; D009926:Organ Preservation / Q000379:methods*; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D010758:Phosphorus; D011687:Purines / Q000378:metabolism; D011887:Raffinose; D051381:Rats; D013997:Time Factors
C099594:CRMBM solution; D002314:Cardioplegic Solutions; D010710:Phosphates; D011687:Purines; D010725:Phosphocreatine; D010758:Phosphorus; D000493:Allopurinol; D000255:Adenosine Triphosphate; D003402:Creatine Kinase; D005978:Glutathione; D011887:Raffinose